Data backs Orthofix cellular bone allograft for lumbar fusio

Orthofix (Nasdaq:OFIX) today announced positive results from a clinical study evaluating its Trinity Elite cellular bone allograft (CBA).

Related Keywords

, Kevin Kenny , Neurology International , Orthofix Trinity Elite , Trinity Elite , Joshua Wind , Sibley Memorial Hospital , Orthofix President , Global Spine Kevin ,